• Consumers are increasingly conscientious about companies’ performance on metrics involving their environmental, social and governance (“ESG”) profiles
• Energy-use optimization advisory firm Correlate Infrastructure Partners helps companies improve their sustainability efforts and their transparency on what they’re accomplishing
• CIPI’s analytical capabilities not only help clients improve their carbon emission standards, but their operational profitability in the process
• Companies are increasingly adopting ESG standards in response to international governmental efforts to forestall rising planetary temperatures and anticipated severe weather growth

Purpose-driven companies no longer rely on their vision and mission statements to do the work of communicating their values. Environmental, social and governance (“ESG”) disclosures now often have the capability to provide measurable information on a business’s commitment to their communities. And ESG metrics are increasingly assuming competitive significance with consumers. NewsDirect recently noted reports by research technology company Glow, analysts at NielsenIQ and researchers at PwC that found ESG metrics trending among conscientious product purchase decisions. “In May 2022, Glow found that 1 in 4 consumers in the U.S., Australia and the U.K. started, switched or stopped use of a brand with sustainability and social responsibility concerns as a factor,” the report states (https://ibn.fm/DbQC9). “All of this is not to say that opinions about a company’s performance on sustainability, diversity or fair trade is the sole reason for switching brands. However, data shows these perceptions can be a significant decision point — and in a competitive marketplace among brands, they can tip the scales.” Correlate Infrastructure Partners (OTCQB: CIPI), a company established to help clients fight climate change through improved facilities energy use, see sustainability not only as a socially responsible thing to do, but a way of improving corporate profitability. CIPI’s platform allows companies to meet their ESG goals while increasing rent and operating revenues, drawing on the mutually constructive capabilities of its subsidiaries to identify opportunities for reducing pollution, ways to improve their carbon footprint, and methods for financing needed improvements. Financial services giant Morgan Stanley underlines the operational importance of improving buildings’ energy use footprints, stating in an investor briefing that “Overall, the real estate investment team estimates that a typical office building that integrates sustainable practices could help reduce building expenses by 3 to 30 percent, creating $3.5 billion to $34.9 billion of asset value in the top 10 U.S. markets in the process” (https://ibn.fm/fhD8Z). NewsDirect’s report cited findings this year from the Wharton School of the University of Pennsylvania that a rising percentage of retail shoppers in the United States are willing to spend more on the products they buy if the brands are demonstrating socially and environmentally responsible performance. The report noted the increasing sentiment occurred across all generations over the last two years. In June, the International Energy Agency’s latest World Energy Investment 2022 report described findings that clean energy investment grew by 12 percent year-over-year, which was significant compared to the 2 percent growth recorded during the first five years after the Paris Accords of 2015 that produced international agreement on standards for reducing carbon emissions in an effort to stem rising global temperatures. “The path to full decarbonization will take ambition and intentional execution,” CIPI CEO and President Todd Michaels stated in June (https://ibn.fm/buxFE). “By teaming up with industry innovators and experts, we can guide commercial real estate owners in creating new revenue and rent opportunities from their existing energy assets.” For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Dawson James brings 20 years of investment banking experience that will enhance LRDC presence in public financial markets
• Financial advisory agreement outlines valuable advice, consultations regarding uplisting, business and financial planning, corporate organization and structure, and more
• Laredo Oil is an oil exploration, production company primarily engaged in acquisition and exploration efforts for mineral properties

Uplisting to a higher exchange can bring significant advantages to companies, and Laredo Oil (OTC: LRDC) is eyeing that possibility and making strategic moves in that direction. Laredo, an exploration and production company specializing in conventional and enhanced oil recovery (“EOR”) techniques targeting mature and declining oil fields, recent signed a financial advisory agreement with Dawson James Securities aimed to provide essential insight and support as the company focuses on future growth (https://ibn.fm/eh1HO). “Dawson James brings 20 years of investment banking experience and expertise which, I feel, will enhance our presence in the public financial markets,” said Laredo Oil CEO and chair Mark See. According to the announcement, the agreement calls for Dawson to “provide advice to and consult with the company concerning business and financial planning, corporate organization and structure, and private and public equity and debt financing, as well as potential uplisting and other such matters mutually agreed upon.” Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the life science/health care, technology, clean tech and consumer spaces. “We are a full-service investment banking firm with research, institutional and retail sales, and execution trading and corporate services,” the company states (https://ibn.fm/EeyT6). “By investing the time required to completely understand your business, we can provide an appropriate capital transaction structure and strategy including direct investment through our independent fund,” the statement continues. “Our team will assist in crafting your vision and shaping your message for the capital markets.” Dawson James is “looking forward to working closely with Mark and the Laredo Oil team, assisting them in achieving all their business and financial goals,” added Frank Terzo, managing director of investment banking at Dawson James. Laredo Oil is an oil exploration and production company primarily engaged in acquisition and exploration efforts for mineral properties. In addition to pursuing conventional oil recovery methods in selected oil fields, Laredo Oil plans to locate and acquire mature oil fields, with the intention of recovering “stranded” oil using enhanced recovery methods. For more information, visit the company’s website at www.Laredo-Oil.com. NOTE TO INVESTORS: The latest news and updates relating to LRDC are available in the company’s newsroom at https://ibn.fm/LRDC

• D-Wave is the only provider building both annealing and gate-model quantum computers that offers solutions to complex problems that classical computers may not be able to process
• The company provides value through practical applications for problems across logistics, artificial intelligence, materials science, drug discovery, scheduling, fraud detection, financial modeling, and more.
• D-Wave is hosting the upcoming Qubits conference (October 11-13, 2022), one of quantum industry’s premiere and informative quantum for business events, with speakers featuring quantum pioneers including Mastercard, Johnson & Johnson, Fidelity, Schlumberger, and more

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems and software solutions, is focused on delivering customer value through practical applications for problems such as logistics, artificial intelligence, materials science, drug discovery, scheduling, fraud detection, and financial modeling. The company is the only provider building both annealing and gate-model quantum computers. D-Wave’s quantum computers use qubits, representing many values between zero and one, as well as zero and one simultaneously. Classical computers can only process set values of zero or one, making the ability to solve many complex problems impossible with classical systems. D-Wave’s quantum computing products enable companies to solve complex problems across multiple industries, including financial services, manufacturing and logistics, and life sciences sectors. “We are heralding in the next wave of computing. Just like the creation of the PC, the emergence of the internet, and the proliferation of smartphones and voice assistants, it is our belief that quantum will have far-reaching and industry-disrupting impact, especially in the financial services sector,” said Alan Baratz, CEO of D-Wave, commenting on a recent agreement between the company and Mastercard to build innovative quantum computing applications and transform customer experiences (https://ibn.fm/VjeIC). “D-Wave and Mastercard have a shared vision of harnessing the power of technology to positively affect business and society. This alliance supports that vision by delivering quantum innovation that will tackle increasingly complex problem sets across applications like optimized loyalty programs, fraud management, and anti-money laundering in financial services and, ultimately, unlock more value for customers,” Baratz explained. D-Wave’s relentless pursuit of practical quantum computing has resulted in its quantum computing technology being used by some of the world’s most advanced enterprises today. More than two dozen of the Forbes Global 2000 use D-Wave, as well as blue-chip industry leaders such as Volkswagen, Deloitte, BBVA, NEC Corporation, Save-On-Foods, DENSO, and Lockheed Martin. Learn more about how D-Wave impacts businesses using real-world quantum applications by visiting https://ibn.fm/2df7F. D-Wave’s current product offerings include Advantage(TM), a fifth-generation quantum computer; Leap(TM), the only real-time quantum cloud service; Launch(TM), a quantum computing onboarding service; and Ocean(TM), a full suite of open-source programming tools. One of D-Wave’s current customers (Save-On-Foods) says that by using quantum-hybrid solvers that harness the Advantage system, they have been able to deal with “in excess of four million decision variables that all have interactions with each other.” The company recently announced the availability of its Advantage2(TM) experimental prototype, which is expected to become its sixth-generation quantum system. The prototype was designed to illustrate the upcoming system’s abilities, which is expected to feature 7000+ qubits, and enables 20-way connectivity and increased coherence. Additionally, D-Wave launched the CQM hybrid solver, allowing businesses to solve constrained quadratic optimization problems with continuous variables. CQM enables D-Wave to expand the types of use cases that can benefit from the company’s quantum-hybrid solutions (https://ibn.fm/hhdEt). In addition to the current selection of quantum technology and applications, the company has begun preparations for the Qubits 2022 conference. The Qubits 2022 free virtual conference, October 11-13, is one of the industry’s premier conferences on quantum computing, focusing on quantum for business and an opportunity to network with quantum computing experts and practitioners. Investors are invited to attend one of the quantum industry’s most informative conferences and hear from quantum pioneers from Mastercard, Johnson & Johnson, Fidelity, Schlumberger, and more. Registration for the event is currently open. Visit https://www.qubits.com to register. For more information about D-Wave and to discover more about quantum systems, cloud services, application development tools, and professional services to support the end-to-end quantum journey, visit the company’s website at www.DWavesys.com. NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

• The newly passed Inflation Reduction Act provides a litany of incentives for homeowners to transition to renewable energies
• GeoSolar Technologies SmartGreen(TM) package uses leading edge solar, geothermal and air quality technologies to maximize home efficiency with minimal environmental impact
• GeoSolar’s process is an end-to-end solution to help people better understand all the incentives available and financing options to realize a solid ROI and eventually generate clean, free energy

The passage of the “anti-inflation” bill this month should conjure up a lot more thoughts than just talking points about the bill’s name. Fact is, the landmark climate and healthcare bill, no matter what it is called, is not going to be enough to end dependence upon fossil fuels, but it does earmark plenty of funds to support wider adoption of greener technologies, reduce foreign supply dependence through domestic infrastructure, and extends tax credits that could nudge consumers into alternative energies. The bill encourages a holistic approach to transitioning towards renewable energies, a comprehensive approach that falls into the wheelhouse of GeoSolar Technologies (“GST”), as a provider of integrated services for carbon-free homes. There is nothing simple about wrapping your brain around a massive piece of legislation like the Inflation Reduction Act. Further, as brilliantly described by a Columbia Climate School article, no one can even be sure about the future of greenhouse gases or what the transition to clean energy will look like. To have that type of arrogance would be akin to positing the (apocryphal) 19^th Century quote of U.S. Patent Office Commissioner Charles Duell that “everything that can be invented has been invented.” What is certain is that the U.S. government is offering a host of incentives to switch to alternative energies. According to the White House, the new law provides $14,000 in direct consumer rebates for families to buy heat pumps and other energy-efficient home appliances. The solar tax credit that has repeatedly reached its end of life only to be resurrected in the last hour has not only been extended, but it has also been increased to a 30% tax credit (from 26% and plans to be reduced to 22%).  The bill also included up to $7,500 in tax credits for new electric vehicle purchases and $4,000 for used EVs, amongst other things. These incentives dovetail with the SmartGreen(TM) package of GeoSolar Technologies. The Denver-based company runs the gamut for maximizing efficient, clean living, with its expertise in HVAC (heating, ventilation, and cooling), electricity, and air purification for existing and new homes. The package is undergirded by using the natural consistencies of the sun and the ground to provide a home with the essentials. An initial analysis and design will result in removing any toxins within the envelope of the structure. Integrated floor loops combined with exterior geothermal ground loops, ductwork, heat pump, and other tech deliver year-round heating, cooling, and hot water. The company’s CERV® Air Filtration system and associated mobile application ensures healthy and safe indoor air quality that prevents COVID-19 and other pollutants. Rooftop photovoltaic solar panels are properly sized to provide the house with electricity and can be used to power a new electric car charging station. The return on investment will vary for the homeowner depending on a few factors, including the local utility rate, payments from utility and amount of electricity sold to the utility, and degree of electrification. For instance, EV charging against the high price of gasoline accelerates the recouping initial capital outlays. As it goes, GeoSolar offers different financing options through its partners to help homeowners with upfront costs. Once all investment is recouped, the homeowner’s electricity is free sans any maintenance costs or service fees charged by a utility to connect to the power grid. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• LQwD’s BTC capacity on The Lightning Network exceeds 30 BTC with over 300 payment channels operating across 17 countries with plans to expand to 24 countries by the end of the current quarter
• The debut of Bitcoin occurred during the recession of 2008 by an anonymous individual or group later named “Satoshi Nakamoto”
• The fractionalized form of bitcoin is named after Nakamoto, with 1 satoshi equivalent to 0.00000001 BTC
• The cryptocurrency market value is expected to reach US $4.94 billion by 2030

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive Bitcoin adoption, has been operating on The Lightning Network since November 2021, amassing a capacity of over 30 BTC with more than 300 channels facilitating BTC transactions for micropayment users. The current BTC capacity of The Lightning Network has exceeded 4.5k BTC to date (over US $110,000) (https://ibn.fm/Ftopd). LQwD currently has a network of 19 nodes spanning 17 countries and plans to increase to 24 by the end of the current quarter. The concept of Bitcoin appeared in 2008, when the domain name “Bitcoin.org” was registered. In October 2008, an individual or group assuming the name Satoshi Nakamoto announced the “Cryptography Mailing List,” which has become the infamous white paper of the registered domain and the standard in which Bitcoin operates today. The first bitcoin block was mined on January 3, 2009 and is most commonly known as “Block 0” or the “genesis block.” The block contains the text, “The Times 03/Jan/2009 Chancellor on brink of second bailout for banks,” – providing proof that the block was mined on or after that date and set the tone for the introduction of cryptocurrency as a viable alternative in the wake of the recession (https://ibn.fm/gv5hY). Although anonymous, Satoshi Nakamoto has become synonymous with the inception of Bitcoin and decentralized currency. The fractionalized form of bitcoin is named after the mysterious creator and can be sent or received in increments of 0.00000001 BTC, equivalent to 1 satoshi. The Lightning Network has allowed users to complete payments using the layer 2 protocol quicker than traditional blockchain and even faster than some of the world’s leading institutions. Payments made using The Lightning Network offer faster settlement times, cheaper fees, and higher levels of security than their centralized counterparts. Growing public interest has led to an increase in the global cryptocurrency market size, from US $1.49 billion in 2020 to an estimated US $4.94 billion by 2030, experiencing growth at a CAGR of 12.8%, according to Allied Market Research. With the increased need for operational efficiency and transparency in financial payment systems, implementing cryptocurrency as a viable monetary solution appeals to developing and underdeveloped countries worldwide (https://ibn.fm/b0Z1W). LQwD is at the forefront of this movement, leveraging its Bitcoin assets to drive further adoption of The Lightning Network. With the assistance of its proprietary platform as a service (“PaaS”), users can send payments instantly, securely, and inexpensively anywhere in the world. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

Professionals and executives of biopharma and medical device companies are invited to attend DGE’s 3rd Clinical Trial Agreement Forum, a virtual online livestream event, on September 29-30, 2022. The conference will discuss how the evolution of the virtual clinical trial landscape requires flexibility when designing and modifying clinical trial agreements (“CTAs”). Clinical trials have seen many changes with the advent of virtual clinical trials, where telemedicine and remote monitoring are used. Changes that impact the CTAs include incorporating cybersecurity language, more complicated indemnification, complexities of third-party contracting, and an increase in remote monitoring. The conference will provide insights into novel industry practices and technological trends for successful results as well as speeding up contracting and study start-ups. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.  This DGE forum offers a phenomenal backdrop for discussing and learning important trends, strategies, and challenges faced in negotiating CTAs. Attendees can connect and communicate with industry stalwarts, gaining valuable insights into the latest industry trends regarding patient data and samples through discussions, panels, and more. Featured topics and discussions at the conference:

• Understand the biggest hurdles in negotiating CTAs from sites and sponsors
• Clearly understand the importance and implications of informed consent and future use of patient data and samples
• Embody cybersecurity language in CTAs and remote monitoring agreements
• Define the patient injury provision in subcontracts and clinical trial agreements
• Learn strategies to manage negotiation budgetary restraints and timelines efficiently
• Understand how to protect IP and reduce risks in indemnification and subject injury

The event starts with the chairperson’s address, to be followed by discussions from eminent industry heads respected for their wide knowledge and experience in their respective fields. It’s critical to fully understand the best practices and associated strategies for success in this ever-changing landscape. The event is conducted in a virtual environment where biotech, pharma, and medical device company experts from all over the world can be a part of the event. Understand how better integration between research and clinical care can lead to novel and much more effective contracting strategies. To learn more, please visit https://ibn.fm/yoWrN

• Correlate posts significant increase in Q2 revenue from $1,584 in 2021 to $236,690 in 2022
• Customer deposits have also increased, from $0 during the same period in 2021 to $1,114,154 in Q2 2022, while operating expenses have grown from $4,937 to $1,444,794
• Correlate has attributed the growth to the increased emphasis on commercialization, a shift from previous quarters that focused on product development
• The company hopes to maintain the current trajectory in performance, mainly banking on helping its commercial customers increase their NOI while also maturing its aggressive acquisition strategy

Correlate Infrastructure Partners (OTCQB: CIPI), earlier released its results for the 2021 financial year, where CEO Todd Michaels expressed his optimism for 2022, mainly banking on the learnings from 2021 and building on the company’s focus toward more revenue-generating initiatives. “In 2022, we anticipate revenues to increase with the expansion of operations, sales channels, and repeat business from our 2021 portfolio of national accounts,” Mr. Michaels noted. “The post-pandemic U.S. commercial and industrial market has approximately 6.8 million facilities capable for our solution to increase building owner net income. With only about 3% of those facilities currently being addressed, demand is very high. We couldn’t be more confident and excited about our position for tremendous growth,” he added (https://ibn.fm/P1RJ2). Correlate has since released its financial results for the second quarter (“Q2”) ended June 30, 2022, and the year to date ended June 30, 2022, noting a significant increase in revenue from $1,584 for the same period in 2021 to $236,690. In addition, customer deposits for Q2 totaled $1,114,154, up from $0 for the same period in 2021 (https://ibn.fm/GkrJX). Correlate attributed this significant growth in performance to the shift in the business to commercialization, compared to previous quarters where there was significant product development. In addition, customer deposits accounted for approximately 32% of revenue from contracts with three key customers whose projects are under installation. Operating expenses for Correlate saw an increase from $4,937 over the same period in 2021 to $1,444,794 in Q2 2022. This was credited to higher professional fees associated with acquisition activities and higher wage expenses associated with bringing on board new personnel to support growth. Correlate currently has project opportunities valued at $74 million from recent awards at different stages, including projects that have been awarded agreements in development and contracts that have been executed under installation. In addition, it remains committed to growing as a full-service energy optimization service provider, and its management is confident that it will maintain its current performance trajectory. “By helping commercial customers increase net operating income (“NOI”) through our clean energy solutions, the benefits of our innovative full-service platform becomes a more integral part of real estate asset management,” noted Mr. Michaels. “We are also actively maturing our aggressive acquisition strategy by identifying targets that complement our technology stack or provide fulfillment capabilities in key regions,” he added. So far, Correlate has achieved its revenue forecasts for the 2022 financial year. It looks to maintain its current performance by further focusing on commercialization and growing its customer numbers, ultimately growing its revenue and creating value for its shareholders. For company information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income:  www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals:  www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• New York-based institutional fund manager The Lind Partners has reached an investment agreement with mobile device technology innovator FingerMotion Inc. to provide FingerMotion $4 million that will advance its initiatives
• FingerMotion is focused on varied initiatives for serving China’s massive mobile device user market, its top priority being the rollout of an AppleCare-similar device protection plan the company expects to be popular with users
• Company CEO Martin Shen has stated the protection plan service has the highest potential to yield returns on capital investment in the shortest amount of time
• China has more than 450 million 5G mobile phone users and their need to upgrade their devices and services holds the key to FingerMotion’s strategy

FingerMotion (NASDAQ: FNGR), a U.S.-based company currently focused on serving the huge market for mobile phone-related technologies on the Asian continent, has received an agreement for the infusion of new capital in its enterprise and is preparing to utilize it to drive quick revenue growth. The funding agreement with New York-based institutional fund manager The Lind Partners to obtain gross proceeds of $4 million through an investment by the Lind Global Fund II, LP will help FingerMotion advance various growth strategies in return for a $4.8 million senior convertible note (which includes a 20 percent coupon) and a common stock purchase warrant for buying up to nearly 3.5 million shares of common stock of the company at a select price. “The proceeds from this Investment will be primarily allocated across multiple high-margin and high-growth opportunity initiatives currently underway. In particular, the Company’s highest priority initiative is the full-scale nationwide rollout of its mobile device protection business in China,” CEO Martin Shen stated in the company’s announcement (https://ibn.fm/IsHYa). “This vertical is expected to yield the highest return on capital investment in the shortest amount of time, both strengthening our balance sheet and enabling us to experience transformational revenue growth over the next 12-24 months.” The device protection solution mirrors Apple’s AppleCare service in the Chinese market, which FingerMotion expects to be received by consumers as an innovative and needed product, and one that will be able to pervade the market thanks to FingerMotion’s success in partnering with telecommunications giants China Unicom and China Mobile to reach a wide base of mobile users. Global Times reported there are now more than 450 million 5G mobile phone users in China — the primary target for device protection as they upgrade their products. The report also states all prefecture-level cities have implemented optical network broadband and that the networks have more than 61 million users (https://ibn.fm/9FsBE). The Lind fund’s investment note will have a 24-month maturity. In addition to the mobile device protection service, FingerMotion has been a significant provider of top-up and SMS services and is developing a big data service for reinsurance providers to help assess consumer risk. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Odyssey Health is a medical company focused on developing unique, life-saving medical products that offer clinical advantages for unmet clinical needs
• Recently, the company reported positive results from Cohort I of its Multi-Day Ascending Dosing (“MAD”) portion of its Phase I clinical trial, coming weeks after the successful completion of Phase I Single Ascending Dosing (“SAD”) clinical trial
• The MAD arm thus far shows that the drug is safe and well tolerated
• Odyssey expects to report additional MAD results as they become available

A few weeks after completing its Phase I Single Ascending Dosing (“SAD”) clinical trial, Odyssey Health (OTC: ODYY) recently announced positive results from Cohort I of its Multi-Day Ascending Dosing (“MAD”) portion for its Phase I clinical trial evaluating the efficacy and safety of PRV-002 (https://ibn.fm/2zS5F), the company’s novel drug candidate for treating concussion. For Odyssey, a medical company focused on creating and commercializing unique, life-improving medical products, concussion – a mild traumatic brain injury (“mTBI”) caused by a jolt, bump, or blow to the head – represented an unmet clinical need. Despite its high prevalence in the U.S., with figures showing that as many as five million concussions occur annually (https://ibn.fm/qV6NY), the condition does not have a Food and Drug Administration (“FDA”)-approved drug. “Odyssey’s primary drug candidate is being developed as the first treatment for concussion,” a white paper posted on the company’s website reads (https://ibn.fm/GCgFp). “The drug candidate, PRV-002, is a novel neurosteroid that easily crosses the blood-brain barrier.” The company completed the GMP synthesis of PRV-002 and all pre-clinical efficacy studies, which showed that the drug candidate “improves behavioral (working memory, motor performance, and anxiety levels) and molecular (inflammation, oxidative stress, and swelling) outcomes following brain trauma through an amplified neuroprotective gene response internal to cells in the brain,” and has now embarked on human trials. As part of the ongoing human study, grouped into SAD and MAD portions, Odyssey is administering PRV-002 to healthy human subjects. The successfully completed SAD arm of the Phase I trial involving three cohorts showed the drug was safe and well tolerated, influencing expectations and confidence that PRV-002 will continue to show safety during the MAD portion of the trial. “We have unanimously approved the start of MAD Cohort I,” commented Dallas Hack, MD, member of the Safety Review Committee, following the completion of Phase I SAD trial (https://ibn.fm/WrJDo). “I am especially excited to see the overall low levels of PRV-002 in the blood supporting the hypothesis that more drug is getting to the brain itself when administered with the intranasal device. If this turns out to be the case, not only can the targeted effects of the drug be more efficacious, the drug will likely have less potential side effects.” And with Odyssey having recently announced positive results from Cohort I of the MAD arm of the study, Odyssey’s Phase I clinical trial appears to be ticking all the expected checkboxes. According to the company, the MAD Cohort I (eight healthy subjects) received one low dose of intranasal PRV-002 for five consecutive days, followed by evaluations that showed the drug was safe and well tolerated. “I am very happy to see these positive safety results when dosing for multiple days. PRV-002 appears to be well-tolerated when given intranasally. If PRV-002 is found to be efficacious for concussed patients in the Phase II/III trials, I believe that intranasal brain-targeting will be the key to its success. So far, the intranasal drug/device combination has functioned nicely and has been well-tolerated in the clinical setting,” said Dr. Jacob VanLandingham, the head of drug development for the PRV-002 concussion treatment at Odyssey Health, of the recent positive results. The Phase I MAD clinical trial will involve 16 healthy subjects, with the subsequent cohorts receiving a higher dose than Cohort I. The company expects to report additional MAD results as they become available. For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

The NECANN Conference has evolved into the largest conference on the East Coast, attracting cannabis cultivators, traders, regulators, lawmakers, and enthusiasts, from the East Coast and beyond. The 3rd annual New Jersey Cannabis Convention is being held from September 9-10, 2022, in Atlantic City, New Jersey. This is a well-curated event organized by a highly talented team of professionals with desired expertise and experience. They keep in mind the needs and requirements of the cannabis community and bring together investors, young and veteran cannabis and hemp traders, as well as researchers and lawmakers, all in a common forum. After fighting a tough battle for legalizing both medicinal and recreational cannabis, New Jersey, on February 22nd, 2021, became the fourteenth U.S. state to legalize marijuana completely. Atlantic City has a huge cannabis market waiting to get discovered and tapped by marijuana traders and customers. Also, the city has very limited cannabis dispensary availability to cater to the entire population. The NECANN exhibition will bring the New Jersey cannabis community to the forefront to get discovered by potential investors. The 3rd annual NJ NECANN event will witness an important lineup of speakers and industry veterans. They will share useful insights about the latest industry trends and discuss important issues covering the entire range of topics under the cannabis spectrum. Exhibitors can set up their respective booths to pitch their businesses. The 3rd Annual NJ Cannabis Convention will be a one-of-its-kind experience, to discover more cannabis communities and exchange ideas and information about marijuana businesses. The NECANN team brings in cannabis trade investors and entrepreneurs who are interested in novel and fresh business ideas. Budding entities can leverage the reach of the NECANN platform to gain visibility among potential investors. Established in 2014, NECANN events are one of the largest cannabis conventions offering mammoth networking opportunities. The NECANN events attract Hemp, MMJ, and Cannabis industry professionals, to meet and build critical long-term business ties. The NECANN convention offers a robust platform for local cannabis businesses to showcase their products and services. It allows them to meet the stalwarts of the cannabis community and attract lucrative investments into the developing New Jersey cannabis market. Overall, the event represents a unique opportunity to get in on the ground floor. The NECANN team works tirelessly to cover every aspect of the cannabis industry ranging from inventory, legal issues, packaging, insurance, regulations, security, from testing to cultivation, marketing, and more. To learn more, please visit https://ibn.fm/qwr8m